样式: 排序: IF: - GO 导出 标记为已读
-
CD20 + T lymphocytes in isolated Hashimoto’s thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-20 Ilaria Stramazzo, Giorgio Mangino, Silvia Capriello, Giovanna Romeo, Silvia Martina Ferrari, Poupak Fallahi, Maria Flavia Bagaglini, Marco Centanni, Camilla Virili
-
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-18 F. Pecori Giraldi, F. Ferraù, M. Ragonese, S. Cannavò
-
Familial states of primary hyperparathyroidism: an update J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-18 F. Cetani, E. Dinoi, L. Pierotti, E. Pardi
-
Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-17 M. Chianelli, L. Busetto, R. Vettor, B. Annibale, A. Paoletta, E. Papini, A. Albanese, M. Carabotti, D. Casarotto, G. De Pergola, O. E. Disoteo, I. Grandone, G. Medea, E. Nisoli, M. Raffaelli, S. Schiff, F. Vignati, M. Cinquini, M. Gonzalez-Lorenzo, V. A. Fittipaldo, S. Minozzi, M. Monteforte, A. C. Tralongo, R. Novizio, A. Persichetti, I. Samperi, A. Scoppola, G. Borretta, M. Carruba, M. G. Carbonelli
Aim This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification. Methods Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a general practitioner, a nutritionist, a nurse and a patients’ representative acted as
-
Brain morphometry and estimation of aging brain in subjects with congenital untreated isolated GH deficiency J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-16 Keila R. Villar-Gouy, Carlos Ernesto Garrido Salmon, Roberto Salvatori, Michael Kellner, Miriam P. O. Krauss, Tâmara O. Rocha, Erick Almeida de Souza, Vanderlan O. Batista, Ângela C. Leal, Lucas B. Santos, Enaldo V. Melo, Alécia A. Oliveira-Santos, Carla R. P. Oliveira, Viviane C. Campos, Elenilde G. Santos, Nathalie O. Santana, Francisco A. Pereira, Rivia S. Amorim, José Donato-Junior, José Augusto
-
An objective way to predict remission and relapse in Cushing disease using Bayes’ theorem of probability J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-15 N. Gupta, B. D. Konsam, R. Walia, S. K. Bhadada, R. Chhabra, S. Dhandapani, A. Singh, C. K. Ahuja, N. Sachdeva, U. N. Saikia
-
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-11 E. Formisano, E. Proietti, C. Borgarelli, S. G. Sukkar, M. Albertelli, M. Boschetti, L. Pisciotta
-
Simplified integration of optimal self-management behaviors is associated with improved HbA1c in patients with type 1 diabetes J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-11 C. Deng, Y. Xie, F. Liu, X. Tang, L. Fan, X. Yang, Y. Chen, Z. Zhou, X. Li
-
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-05 L. Schubert, A. M. Mbekwe-Yepnang, J. Wassermann, Y. Braik-Djellas, L. Jaffrelot, F. Pani, G. Deniziaut, C. Lussey-Lepoutre, N. Chereau, L. Leenhardt, M- O. Bernier, C. Buffet
-
Asprosin: its function as a novel endocrine factor in metabolic-related diseases J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-03
Abstract Background and purpose Asprosin was discovered as a new endocrine hormone originating from fibrillin-1 cleavage that plays a crucial role in various metabolic-related diseases, such as obesity, nonalcoholic fatty liver disease (NAFLD), diabetes, polycystic ovary syndrome (PCOS), and cardiovascular diseases. The purpose of this review is to describe the recent advancements of asprosin. Method
-
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-02 A. Dei Cas, M. M. Micheli, R. Aldigeri, S. Gardini, F. Ferrari-Pellegrini, M. Perini, G. Messa, M. Antonini, V. Spigoni, G. Cinquegrani, A. Vazzana, V. Moretti, P. Caffarra, R. C. Bonadonna
Purpose According to preclinical evidence, GLP-1 receptor may be an actionable target in neurodegenerative disorders, including Alzheimer’s disease (AD). Previous clinical trials of GLP-1 receptor agonists were conducted in patients with early AD, yielding mixed results. The aim was to assess in a proof-of-concept study whether slow-release exenatide, a long-acting GLP-1 agonist, can benefit the cognitive
-
Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-01 M. Rossi, S. Terreri, G. Battafarano, I. Rana, P. S. Buonuomo, L. Di Giuseppe, M. D’Agostini, O. Porzio, J. Di Gregorio, Cristiana Cipriani, A. Jenkner, M. V. Gonfiantini, A. Bartuli, A. Del Fattore
Purpose Gorham-Stout disease is a very rare disorder characterized by progressive bone erosion and angiomatous proliferation; its etiopathogenesis is still unknown, and diagnosis is still performed by exclusion criteria. The alteration of bone remodeling activity has been reported in patients; in this study, we characterized circulating osteoclast and osteogenic precursors that could be important to
-
A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-01 S. Zhu, Z. Wu, W. Wang, L. Wei, H. Zhou
-
Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-01 G. I. Baroncelli, M. R. Sessa, C. Pelosini, S. Bertelloni, A. Michelucci, B. Toschi, P. Piaggi, D. Peroni, P. Comberiati
-
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-04-01 E. Gatta, V. Maltese, E. Cimino, M. Cavadini, V. Anelli, E. Di Lodovico, E. Piovani, I. Zammarchi, G. Gozzoli, B. Agosti, I. Pirola, A. Delbarba, A. Girelli, C. Buoso, F. Bambini, D. Alfieri, W. Bremi, P. Facondo, R. Lupo, F. Bezzi, M. Fredi, A. M. Mazzola, E. Gandossi, M. Saullo, F. Marini, M. Licini, L. C. Pezzaioli, L. Pini, F. Franceschini, C. Ricci, C. Cappelli
-
Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-26 B. Xu, B. Kang, S. Li, S. Fan, J. Zhou
-
Very low serum IGF-1 levels are associated with vertebral fractures in adult males with beta-thalassemia major J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-25 G. Costanzo, A. Naselli, M. L. Arpi, T. Piticchio, R. Le Moli, A. Belfiore, F. Frasca
-
The need for the GREAT+ score to predict relapse in Graves’ disease: a questionnaire among patients and internal medicine specialists J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-25 H. I. Jansen, C. Heuveling van Beek, P. H. Bisschop, A. C. Heijboer, E. Bruinstroop, A. Boelen
-
Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-24 F. Coperchini, A. Greco, M. Rotondi
-
Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-23 A. La Salvia, B. Marcozzi, C. Manai, R. Mazzilli, L. Landi, M. Pallocca, G. Ciliberto, F. Cappuzzo, A. Faggiano
-
Sleeve gastrectomy links the attenuation of diabetic kidney disease to the inhibition of renal tubular ferroptosis through down-regulating TGF-β1/Smad3 signaling pathway J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-21 C. Liu, M. Zhong, X. Jin, J. Zhu, Y. Cheng, L. Li, Q. Xu, Q. Liu, H. Ding, G. Zhang
-
Evaluation of pituitary function and metabolic parameters in patients with traumatic maxillofacial fractures J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-19 O. O. Daloglu, M. C. Unal, C. A. Kemaloglu, O. F. Bolatturk, I. Ozyazgan, F. Tanriverdi, A. Coruh, F. Kelestimur
-
Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-19 F. Bioletto, M. Sibilla, V. Gasco, E. Ghigo, S. Grottoli
-
Exposure to alcohol or lead? Chronic gout in baroque depictions of obese Silenus and Bacchus J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-19 B. Lefrère, L. Groussin, Y. Allanore
-
Recurrence in acromegaly: two tertiary centers experience and review of the literature J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-19
Abstract Background Recurrence of acromegaly after successful surgery is a rare event, but no clear data are reported in the literature about its recurrence rates. This study aimed to evaluate the recurrence rate in a series of acromegalic patients treated by transsphenoidal surgery (TSS) with a long follow-up. Methods We retrospectively analyzed data from 283 acromegalic patients who underwent TSS
-
Relationship between diabetic peripheral neuropathy and adherence to the Mediterranean diet in patients with type 2 diabetes mellitus: an observational study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-18 S. Zúnica-García, J. J. Blanquer-Gregori, R. Sánchez-Ortiga, M. I. Jiménez-Trujillo, E. Chicharro-Luna
-
Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-18 G. Della Pepa, R. Lupoli, M. Masulli, R. Boccia, R. De Angelis, S. Gianfrancesco, R. Piccolo, C. Rainone, A. A. Rivellese, G. Annuzzi, L. Bozzetto
Purpose Metabolic dysfunction-associated steatotic liver disease (MASLD) may have distinctive pathophysiological features in type 1 diabetes (T1D). We evaluated the independent role of blood glucose control on MASLD in T1D. Methods In a cross-sectional study on 659 T1D adult patients, MASLD was assessed by the Fatty Liver Index (FLI) and the Hepatic Steatosis Index (HSI). Anthropometric, biochemical
-
Overt hypothyroidism in pregnancy and language development in offspring: is there an association? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-18
Abstract Purpose Overt hypothyroidism during pregnancy is linked to various obstetric complications, such as premature birth and fetal death. While some studies have shown that maternal hypothyroidism can impact a child's Intelligence Quotient (IQ) and language development, findings are controversial. The aim of this study was to explore the connection between treated maternal hypothyroidism during
-
Metabolomic profiles of ovariectomized mice and their associations with body composition and frailty-related parameters in postmenopausal women J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-17 S. J. Kim, Y. Jo, S. J. Park, E. Ji, J. Y. Lee, E. Choi, J.-Y. Baek, I. Y. Jang, H.-W. Jung, K. Kim, D. Ryu, H. J. Yoo, B.-J. Kim
-
Analysis of the finasteride treatment and its withdrawal in the rat hypothalamus and hippocampus at whole-transcriptome level J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-17
Abstract Purpose As reported in patients treated for androgenetic alopecia with finasteride (i.e., a blocker of the enzyme 5 alpha-reductase) and in an animal model, side effects affecting sexual, psychiatric, neurological, and physical domains, may occur during the treatment and persist with drug suspension. The etiopathogenesis of these side effects has been poorly explored. Therefore, we performed
-
Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-15 D. Rendina, A. Falchetti, D. Diacinti, F. Bertoldo, D. Merlotti, S. Giannini, L. Cianferotti, G. Girasole, M. Di Monaco, S. Gonnelli, N. Malavolta, S. Minisola, F. Vescini, M. Rossini, B. Frediani, I. Chiodini, F. Asciutti, L. Gennari
-
Temporal trends in the clinical presentation of Graves’ orbitopathy: a single–center retrospective study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-15 R. Le Moli, A. Naselli, F. Lo Giudice, G. Costanzo, F. Frasca, A. Belfiore
-
Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-15 J. Pinto, N. Cera, D. Pignatelli
-
CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-14 C. Wang, Z. Wang, L. Fu, J. Du, F. Ji, X. Qiu
-
Hsa_circ_0008360 promotes high glucose-induced damage in HK-2 cells via miR-346/WNT2B axis J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-12 L. Zhang, X. Wang
-
Once upon a time: the glucagon stimulation test in diagnosing adult GH deficiency J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-10 D. Cuboni, M. Caputo, E. Ghigo, G. Aimaretti, V. Gasco
-
Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-09 N. Subramanian, A. Wiik, E. Rullman, M. Melin, T. R. Lundberg, J. Flanagan, M. Holmberg, A. Dekanski, C. Dhejne, S. Arver, T. Gustafsson, J. Laurencikiene, D. P. Andersson
-
Enhancing gestational diabetes mellitus risk assessment and treatment through GDMPredictor: a machine learning approach J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-09 J. Xing, K. Dong, X. Liu, J. Ma, E. Yuan, L. Zhang, Y. Fang
-
Vitamin D and risk of developing type 2 diabetes in the SUN project: a prospective cohort study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-08 A. Valer-Martinez, C. Sayon-Orea, J. A. Martinez, F. J. Basterra-Gortari, M. A. Martinez-Gonzalez, M. Bes-Rastrollo
-
Thyroiditis and COVID-19: focus on pediatric age. A narrative review J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-08 F. d’Aniello, M. E. Amodeo, A. Grossi, G. Ubertini
-
Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-07 M. Tsoli, H. Wilson, P. Armonis, L. Kamieniarz, J. Thuringer, R. Mirnezami, M. Caplin, G. Kaltsas, C. Toumpanakis
-
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-05 A. Giandalia, A. Nicolucci, M. Modugno, G. Lucisano, M. C. Rossi, V. Manicardi, A. Rocca, G. Di Cianni, P. Di Bartolo, R. Candido, D. Cucinotta, G. T. Russo
-
Quality of care and clinical inertia in the management of cardiovascular risk factors in patients with type 1 and type 2 diabetes: data from AMD annals J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-04 A. Da Porto, R. Candido, A. Rocca, V. Manicardi, A. Nicolucci, C. Miranda, E. Cimino, P. Di Bartolo, G. Di Cianni, G. Russo
Background Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, and for this reason, all guidelines for CV risk management provide the same targets in controlling traditional CV risk factors in patients with type 1 or type 2 diabetes at equal CV risk class. Aim of our study was to evaluate and compare CV risk management in patients with type 1 and type
-
Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-03-01 B. Cedeno-Veloz, L. Lozano-Vicario, A. Rodríguez-García, F. Zambom-Ferraresi, A. Galbete, J. Fernández-Irigoyen, E. Santamaría, A. García-Hermoso, R. Calvani, R. Ramírez-Vélez, M. Izquierdo, N. Martínez-Velilla
-
Saint Augustine in his studio by Sandro Botticelli (1445–1510): a representation of Hemochromatosis? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-28 D. de Campos
-
ACROMORFO study: gait analysis in a cohort of acromegalic patients J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-28 V. Cimolin, C. Premoli, G. Bernardelli, E. Amenta, M. Galli, L. Donno, D. Lucini, L. M. Fatti, B. Cangiano, L. Persani, G. Vitale
Purpose In acromegaly, skeletal complications resulted to be associated with low quality of life (QoL) and high risk of falls. The aim of the present study was to perform a quantitative assessment of movement through gait analysis technique in patients with acromegaly. Study population Thirty-three acromegalic patients [9 with active disease (AD), 14 with controlled disease (CD) and 10 with disease
-
HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4 J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-27 J. Yu, J. Da, F. Yu, J. Yuan, Y. Zha
-
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapy J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-24 Francesca Spada, Massimo Milione, Patrick Maisonneuve, Natalie Prinzi, Valeria Smiroldo, Elena Bolzacchini, Sara Pusceddu, Carlo Carnaghi, Fausto Sessa, Stefano La Rosa, Silvia Uccella, Nicola Fazio
-
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-22 G.-Q. Zhang, C. Xi, N.-T. Ju, C.-T. Shen, Z.-L. Qiu, H.-J. Song, Q.-Y. Luo
-
Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-22 Richard J. Fantus, Daniel R. Greenberg, Cecilia Chang, Brian T. Helfand, Jianfeng Xu, Jun Wei, Jonathan E. Shoag, Ajay K. Nangia, Robert E. Brannigan, Joshua A. Halpern
-
Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-22
Abstract Background Limited information exists on postoperative hypocortisolism and hypothalamus–pituitary–adrenal axis recovery in patients with adrenal incidentaloma following unilateral adrenalectomy. We evaluated frequency of postoperative hypocortisolism and predictors for recovery in non-aldosterone-producing adrenocortical adenoma patients after unilateral adrenalectomy. Methods A retrospective
-
Communication of the diagnosis to Klinefelter subjects: an observational study on a key moment of the patient’s life J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-20
Abstract Purpose Klinefelter syndrome (KS) is the most prevalent sex chromosome disorder among males. The communication of the KS diagnosis holds significant implications for the diagnosis's acceptance. Recently, the increased use of prenatal diagnostic procedures has raised the question of whether, when, and by whom information, once provided to parents, should be communicated to their children/adolescents
-
Transition from pediatric to adult care in patients with Turner syndrome in Italy: a consensus statement by the TRAMITI project J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-20
Abstract Purpose Transition from pediatric to adult care is associated with significant challenges in patients with Turner syndrome (TS). The objective of the TRansition Age Management In Turner syndrome in Italy (TRAMITI) project was to improve the care provided to patients with TS by harnessing the knowledge and expertise of various Italian centers through a Delphi-like consensus process. Methods
-
Estimate and needs of the transgender adult population: the SPoT study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-19 A. D. Fisher, M. Marconi, G. Castellini, J. D. Safer, S. D’Arienzo, M. Levi, L. Brogonzoli, R. Iardino, C. Cocchetti, A. Romani, F. Mazzoli, P. Matarrese, V. Ricca, L. Vignozzi, M. Maggi, M. Pierdominici, J. Ristori
-
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-18
Abstract Aim Oral semaglutide, an innovative orally administered GLP-1 receptor agonist for type 2 diabetes (T2D) management was herein evaluated for its effectiveness in a multi-center retrospective real-world study. Methods We included new-users of oral semaglutide from 18 specialist care centres and collected retrospective data on baseline clinical characteristics. Updated values of HbA1c and body
-
Novel variants ensued genomic imprinting in familial central precocious puberty J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-17
Abstract Introduction Central precocious puberty (CPP) is characterized by the early onset of puberty and is associated with the critical processes involved in the pubertal switch. The puberty-related gene pool in the human genome is considerably large though few have been described in CPP. Within those genes, the genomic imprinting features of the MKRN3 and DLK1 genes add additional complexity to
-
Should there be a paradigm shift for the evaluation of isthmic thyroid nodules? J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-16 Yağmur Babayid, Asena Gökçay Canpolat, Atilla Halil Elhan, Koray Ceyhan, Demet Çorapçıoğlu, Mustafa Şahin
-
Long-term prognostic value of thyroid hormones in left ventricular noncompaction J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-15 L. Liu, S. Cai, A. Chen, Y. Dong, L. Zhou, L. Li, Z. Zhang, Z. Hu, Z. Zhang, Y. Xiong, Z. Hu, Y. Li, M. Lu, L. Wu, L. Zheng, L. Ding, X. Fan, Y. Yao
-
Serum levels of adiponectin differentiate generalized lipodystrophies from anorexia nervosa J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-15 G. Ceccarini, C. Pelosini, M. Paoli, N. Tyutyusheva, S. Magno, D. Gilio, L. Palladino, M. R. Sessa, S. Bertelloni, F. Santini
-
The impact of telehealth education on self-management in patients with coexisting type 2 diabetes mellitus and hypertension: a 26-week randomized controlled trial J. Endocrinol. Investig. (IF 5.4) Pub Date : 2024-02-14 Hongjiang Ye, Ling Lin, Dongmei Zhong, Pin Chen, Xiaoqiong He, Zhurong Luo, Ping Chen